Vimarsana
Biggest News Aggregation in the World

Page 49 - Current Reports News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Reports. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Reports Today - Breaking & Trending Today

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board - Vimarsana News

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and...

Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections - Vimarsana News

Barinthus Bio Announces Topline Data from Phase 1b/2 APOLLO Trial of VTP-200 in Persistent High-Risk Human Papillomavirus (HPV) Infections

Primary safety endpoint met; VTP-200 was generally well-tolerated, with no treatment-related grade 3 or higher adverse events or serious AEs . Positive trends in clearance rate for both high-risk HPV...

Southern First Bancshares : Reports Results for First Quarter 2024 - Form 8-K - Vimarsana News

Southern First Bancshares : Reports Results for First Quarter 2024 - Form 8-K

Southern First Reports Results for First Quarter 2024 Greenville, South Carolina, April 18, 2024 - Southern First Bancshares, Inc. , holding company for Southern First Bank,...

Kermit Facility Operational Update - Vimarsana News

Kermit Facility Operational Update

As previously reported, on Sunday, April 14th, a mechanical fire occurred at the Atlas Energy Solutions Inc. mine in Kermit, Texas. Atlas remains grateful that all personnel at the site, including...

Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated - Vimarsana News

Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated

Adaptimmune Therapeutics plc , a company redefining the treatment of solid tumor cancers with cell therapy, today announced that its strategic collaboration with Genentech entered in 2021, has been...